The incidence of cheilitis during cycles of chemotherapy in breast cancer patients

dc.contributor.authorSukhina, Iryna
dc.contributor.authorSokolova, Iryna
dc.date.accessioned2016-12-06T13:27:07Z
dc.date.available2016-12-06T13:27:07Z
dc.date.issued2016-11-25
dc.description.abstractAccording to various authors, the development of the side effects of cytostatic therapy in the oral cavity occurs in 10–40 % of cases. The conduction of the I cycle of chemotherapy in breast cancer patients was accompanied in 65.4 ± 9.5 % (in 17 of 26 patients) by the development of cheilitis. Marked a further decline in the manifestations of cheilitis in the V and VI CTx cycles – 50.0 ± 10.0 and 34.6 ± 9.5 % respectively. The foregoing dictates the need for monitoring the state of the organs of oral cavity during chemotherapy in breast cancer patients.ru_RU
dc.identifier.citationSukhina I. S. The incidence of cheilitis during cycles of chemotherapy in breast cancer patients / I. S. Sukhina, M. D. Sokoiova // Сучасні погляди на актуальні питання теоретичної, експериментальної та практичної медицини : міжнародна науково-практична конференція, пам’яті професора В. П. Голіка, Харків, 25 листопада 2016 р. : збірник наукових праць. – Харків, 2016. – С. 181–182.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/14998
dc.language.isoenru_RU
dc.subjectcheilitisru_RU
dc.subjectchemotherapyru_RU
dc.subjectbreast cancerru_RU
dc.titleThe incidence of cheilitis during cycles of chemotherapy in breast cancer patientsru_RU
dc.typeThesisru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Сухіна_25_11_2016_Харкiв.pdf
Size:
559.74 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: